Episode Thumbnail
Episode 65  |  31:22 min

FDA Proposes Allowing Medical Device Makers to Summarize Malfunctions: What does that Mean for You?

Episode 65  |  31:22 min  |  11.07.2019

FDA Proposes Allowing Medical Device Makers to Summarize Malfunctions: What does that Mean for You?

00:00
00:00
This is a podcast episode titled, FDA Proposes Allowing Medical Device Makers to Summarize Malfunctions: What does that Mean for You?. The summary for this episode is: The FDA announced a new proposal regarding the bundling of device malfunctions when Medical Device Reporting (MDR). On today’s episode, we have Mike Drues, president of Vascular Sciences, to help us dive into the impact of this proposal and the safety of medical devices. The FDA proposal’s benefits probably outweigh the risks and should be implemented on a small scale. Some highlights of the show include ●Depending on the severity of the malfunction, you are given a specified amount of time to report it. ●What companies should do to make patients and providers aware of issues. ●Should you react immediately or investigate the root cause? A malfunction is a serious matter and time is critical. ●The importance of having decision trees and processes in place before an issue arises. ●A company’s obligations for severe, life-threatening events and reporting timeframes. ●Rather than reporting individual malfunctions, companies will report malfunction summaries every quarter. ●Companies should be proactive and keep an eye on competitors’ similar products that have problems.
The FDA announced a new proposal regarding the bundling of device malfunctions when Medical Device Reporting (MDR). On today’s episode, we have Mike Drues, president of Vascular Sciences, to help us dive into the impact of this proposal and the safety of medical devices. The FDA proposal’s benefits probably outweigh the risks and should be implemented on a small scale. Some highlights of the show include ●Depending on the severity of the malfunction, you are given a specified amount of time to report it. ●What companies should do to make patients and providers aware of issues. ●Should you react immediately or investigate the root cause? A malfunction is a serious matter and time is critical. ●The importance of having decision trees and processes in place before an issue arises. ●A company’s obligations for severe, life-threatening events and reporting timeframes. ●Rather than reporting individual malfunctions, companies will report malfunction summaries every quarter. ●Companies should be proactive and keep an eye on competitors’ similar products that have problems.

More Episodes

Understanding and Handling Different Types of Feedback

Measuring the Impact of AI/ML Technologies on the Current Medical Device Landscape

Post-Pandemic Readiness: Preparing for the Aftermath of COVID-19 on the Medical Device Industry

Tips to Prepare for EU MDR and IVDR as Deadlines Draw Near

How will Emergency Use Authorization (EUA) during Pandemic Influence Future FDA Policy Changes?

Why SaMD Companies Should be Leveraging Pre-Submissions to FDA